Gamma-carboline compounds for the detection of Tau aggregates
Abstract:
The present invention relates to novel compounds of the formula (II) and formula (III) that can be employed in the selective Tau detection of disorders and abnormalities associated with Tau aggregates such as Alzheimer's disease and other tauopathies using Positron Emission Tomography (PET) Imaging.
Public/Granted literature
Information query
Patent Agency Ranking
0/0